Humana (NYSE: HUM) Earnings Q4 2010


View Humana's (NYSE: HUM) Q4 Earnings Report


  • Earnings per share for full-year 2010 totaled $6.47, up 5 percent from 2009
  • Fourth quarter consolidated revenues rose 9 percent to $8.35 billion from $7.63 billion in Q4 2009, with total premium and administrative services fees up 9 percent compared to Q4 2009
  • Consolidated revenues for the full year rose 9 percent to $33.87 billion from $30.96 billion in FY 2009
  • Full-year cash flows from operations totaled over $2.2 billion in 2010
  • The SG&A expense ratio for full-year 2010 was 13.9 percent, up 10 basis points from FY 2009
  • January 2011 Medicare enrollment was better than expected
  • 2011 EPS guidance raised to $5.70 to $5.90

Check out Humana's current earnings estimates from CNN Money

See how HUM is performing right now

Humana's website:

Suggested Articles

Outpatient specialty drugs can be a lucrative income source for not-for-profit hospitals, but Washington presents some risks, Moody's says.

The growing role of data in our lives raises important questions about data access and ownership. Who rightfully owns the data?

Anthem posted $1.18 billion in third-quarter profit, an increase of 23% over the prior-year quarter.